Is GlaxoSmithKline plc's (LON:GSK) 4.8% Dividend Worth Your Time?
Vaccine demand helps GlaxoSmithKline beat forecasts in boost for drugs maker | Evening Standard
GSK Plc (GSK) Dividends
Is it still worth buying GlaxoSmithKline shares after its Haleon spin off? | MoneyWeek
GlaxoSmithKline to Spin Off Haleon Consumer Business in July | Barron's
GSK Demerger – What You Need To Know About Haleon (HLN) – Forbes Advisor UK
Where next for GSK's share price after the demerger and dividend cut announcement?
GSK spinoff starts trading at LSE - what you need to know
Dividend calendar | GSK
Emma Walmsley slashes dividend in radical shake-up to save her job
Why the GlaxoSmithKline dividend makes me nervous | The Motley Fool UK
Dividend calendar | GSK
GSK PLC increases dividend expectations as part of share consolidation
GlaxoSmithKline (LON:GSK) Could Be A Buy For Its Upcoming Dividend
Stock exchange announcements | GSK
GlaxoSmithKline (GSK) Just Announced a Dividend Cut. Why Its Stock Is Rising. | Barron's
New GSK Takes Flight With Strong Quarter, Forecast Boost
GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022
It Might Be Better To Avoid GlaxoSmithKline plc's (LON:GSK) Upcoming 1.1% Dividend
GlaxoSmithKline: 4.57% Dividend Yield, Cure For COVID-19 & HIV | Seeking Alpha
GSK share price | GSK
GlaxoSmithKline: A Dividend Cut Looms, But Shares Look Cheap Regardless - The UK Income Investor
GlaxoSmithKline (LON:GSK): Why Dividend Growth Stalls And Falters | Alex Naamani
GSK shares rise on strong revenues and dividend commitment | Financial Times
